JPWO2020176562A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020176562A5
JPWO2020176562A5 JP2021549986A JP2021549986A JPWO2020176562A5 JP WO2020176562 A5 JPWO2020176562 A5 JP WO2020176562A5 JP 2021549986 A JP2021549986 A JP 2021549986A JP 2021549986 A JP2021549986 A JP 2021549986A JP WO2020176562 A5 JPWO2020176562 A5 JP WO2020176562A5
Authority
JP
Japan
Prior art keywords
raav
seq
aavhu68
galactosylceramidase
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021549986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525848A (ja
JP2022525848A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019794 external-priority patent/WO2020176562A1/en
Publication of JP2022525848A publication Critical patent/JP2022525848A/ja
Publication of JPWO2020176562A5 publication Critical patent/JPWO2020176562A5/ja
Publication of JP2022525848A5 publication Critical patent/JP2022525848A5/ja
Priority to JP2024208739A priority Critical patent/JP2025032175A/ja
Pending legal-status Critical Current

Links

JP2021549986A 2019-02-26 2020-02-26 クラッベ病の治療に有用な組成物 Pending JP2022525848A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024208739A JP2025032175A (ja) 2019-02-26 2024-11-29 クラッベ病の治療に有用な組成物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962810708P 2019-02-26 2019-02-26
US62/810,708 2019-02-26
US201962817482P 2019-03-12 2019-03-12
US62/817,482 2019-03-12
US201962877707P 2019-07-23 2019-07-23
US62/877,707 2019-09-26
US201962916652P 2019-10-17 2019-10-17
US62/916,652 2019-10-17
PCT/US2020/019794 WO2020176562A1 (en) 2019-02-26 2020-02-26 Compositions useful in treatment of krabbe disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024208739A Division JP2025032175A (ja) 2019-02-26 2024-11-29 クラッベ病の治療に有用な組成物

Publications (3)

Publication Number Publication Date
JP2022525848A JP2022525848A (ja) 2022-05-20
JPWO2020176562A5 true JPWO2020176562A5 (https=) 2023-02-22
JP2022525848A5 JP2022525848A5 (https=) 2023-02-22

Family

ID=69941503

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549986A Pending JP2022525848A (ja) 2019-02-26 2020-02-26 クラッベ病の治療に有用な組成物
JP2024208739A Pending JP2025032175A (ja) 2019-02-26 2024-11-29 クラッベ病の治療に有用な組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024208739A Pending JP2025032175A (ja) 2019-02-26 2024-11-29 クラッベ病の治療に有用な組成物

Country Status (16)

Country Link
US (1) US20220118108A1 (https=)
EP (1) EP3931337A1 (https=)
JP (2) JP2022525848A (https=)
KR (1) KR20210132095A (https=)
CN (1) CN114040980A (https=)
AU (1) AU2020229772A1 (https=)
BR (1) BR112021016566A2 (https=)
CA (1) CA3130055A1 (https=)
CL (1) CL2021002248A1 (https=)
CO (1) CO2021011090A2 (https=)
IL (1) IL285776A (https=)
MX (1) MX2021010266A (https=)
PE (1) PE20212072A1 (https=)
SG (1) SG11202108480UA (https=)
TW (1) TW202045728A (https=)
WO (1) WO2020176562A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3177924A1 (en) * 2020-05-12 2021-11-18 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of krabbe disease
KR20230170022A (ko) * 2021-04-12 2023-12-18 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 척수 및 연수 근위축증(sbma) 치료에 유용한 조성물
EP4695389A2 (en) * 2023-04-10 2026-02-18 M6P Therapeutics, Inc. Compositions comprising modified human galactocerebrosidase

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
WO1998046728A1 (en) 1997-04-14 1998-10-22 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant aav product
WO1999061643A1 (en) 1998-05-27 1999-12-02 University Of Florida Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient
ES2340230T3 (es) 1998-11-10 2010-05-31 University Of North Carolina At Chapel Hill Vectores viricos y sus procedimientos de preparacion y administracion.
PT1916258E (pt) 1999-08-09 2014-07-29 Genzyme Corp Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
US7201898B2 (en) 2000-06-01 2007-04-10 The University Of North Carolina At Chapel Hill Methods and compounds for controlled release of recombinant parvovirus vectors
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
AU2003274397A1 (en) 2002-06-05 2003-12-22 University Of Florida Production of pseudotyped recombinant aav virions
US8005620B2 (en) 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
EP1660970A4 (en) 2003-08-01 2007-02-14 Dna Twopointo Inc SYSTEMS AND METHODS FOR BIOPOLYMER TECHNOLOGY
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
WO2006110689A2 (en) 2005-04-07 2006-10-19 The Trustees Of The University Of Pennsylvania Method of increasing the function of an aav vector
EP1777906A1 (en) 2005-06-09 2007-04-25 Matsushita Electric Industrial Co., Ltd. Amplitude error compensating apparatus and orthogonality error compensating apparatus
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
PL3252161T3 (pl) * 2007-06-06 2022-03-07 Genzyme Corporation Terapia genowa dla lizosomalnych chorób spichrzeniowych
WO2010138263A2 (en) 2009-05-28 2010-12-02 University Of Massachusetts Novel aav 's and uses thereof
US20130023033A1 (en) 2010-03-29 2013-01-24 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
FR2977562B1 (fr) 2011-07-06 2016-12-23 Gaztransport Et Technigaz Cuve etanche et thermiquement isolante integree dans une structure porteuse
EA030305B1 (ru) * 2012-08-07 2018-07-31 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Животная модель болезни краббе
US9719106B2 (en) * 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
BR112017005892A2 (pt) 2014-09-24 2017-12-12 Hope City variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
US10195746B2 (en) 2014-09-26 2019-02-05 Teradyne, Inc. Grasping gripper
HK1256341A1 (zh) * 2015-05-15 2019-09-20 明尼苏达大学董事会 用於治疗性递送到中枢神经系统的腺相关物
HK1257801A1 (zh) * 2015-10-28 2019-11-01 宾夕法尼亚州大学信托人 用於基因治疗的腺伴随病毒载体的鞘内给药
US12599636B2 (en) * 2017-01-20 2026-04-14 University of Pittsburgh—of the Commonwealth System of Higher Education Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression
JP7455579B2 (ja) * 2017-02-28 2024-03-26 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 新規アデノ随伴ウイルス(aav)クレードfベクター及びその用途
WO2018160852A1 (en) 2017-03-03 2018-09-07 Cook Medical Technologies, LLC Rapid exchange multiple catheter system
KR102709597B1 (ko) * 2017-10-03 2024-09-26 프리베일 테라퓨틱스, 인크. 리소좀 장애를 위한 유전자 요법

Similar Documents

Publication Publication Date Title
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
JP2021522273A5 (https=)
JP2020510428A5 (https=)
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
RU2019139555A (ru) Генная терапия нейрональных цероидных липофусцинозов
RU2020137429A (ru) Лечение пигментного ретинита
RU2018129159A (ru) Рекомбинантные aav векторы, экспрессирующие остеопротективные гены, включая has2 и лубрицин, пригодные при лечении остеоартрита и сходных заболеваний суставов у млекопитающих
RU2018145010A (ru) Оптимизированные гены и экспрессионные кассеты cln1, и их применение
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
US20230043051A1 (en) Adeno-associated virus vectors based gene therapy for hereditary angioedema
JPWO2022032226A5 (https=)
JP2021520811A (ja) ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックaavベクターならびにその使用
KR20230004617A (ko) 신경계 장애를 치료하기 위한 조성물 및 방법
JP2025514489A (ja) 脳におけるbag3およびタンパク質品質管理
JPWO2020176562A5 (https=)
JPWO2020172490A5 (https=)
JPWO2022015715A5 (https=)
WO2024131237A1 (en) Recombinant viral vector, recombinant adeno-associated virus comprising the same, and uses thereof in treating sialidosis
JPWO2022018171A5 (https=)
WO2023015269A1 (en) Aqp1 gene therapy to prevent radiation induced salivary hypofunction
JP2022551554A (ja) 遺伝子構築物
US20260091140A1 (en) Gene therapy for foxg1 syndrome
KR20250143161A (ko) 시누클레인병증의 치료를 위한 유전자 요법
JPWO2020237130A5 (https=)
KR102626543B1 (ko) AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터